Exact Mass: 393.0469

Exact Mass Matches: 393.0469

Found 98 metabolites which its exact mass value is equals to given mass value 393.0469, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

6-Methylthioguanosine monophosphate

{[(2R,3S,4R,5R)-3,4-dihydroxy-5-[2-imino-6-(methylsulfanyl)-3,9-dihydro-2H-purin-9-yl]oxolan-2-yl]methoxy}phosphonic acid

C11H16N5O7PS (393.0508)


6-Methylthioguanosine monophosphate is a metabolite of tioguanine. Tioguanine, formerly thioguanine, is a drug that is used in the treatment of cancer. It belongs to the family of drugs called antimetabolites. It is a guanine analog. (Wikipedia)

   

Dialifor

O,O-Diethyl {[2-chloro-1-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)ethyl]sulphanyl}phosphonothioic acid

C14H17ClNO4PS2 (393.0025)


   

Rebeccamycin aglycon

Dichloroarcyriaflavin A

C20H9Cl2N3O2 (393.0072)


   

Homidium bromide

Homidium bromide

C21H20N3. Br (393.0841)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors

   

2-(Methylthio)ethyl glucosinolate

{[(e)-[3-(methylsulphanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}propylidene]amino]oxy}sulphonic acid

C10H19NO9S3 (393.0222)


2-(Methylthio)ethyl glucosinolate is found in brassicas. 2-(Methylthio)ethyl glucosinolate is present in horseradish (Armoracia lapathifolia). Present in horseradish (Armoracia lapathifolia). 2-(Methylthio)ethyl glucosinolate is found in horseradish and brassicas.

   

Lorzafone

2-amino-N-({[4-chloro-2-(2-chlorobenzoyl)phenyl](methyl)carbamoyl}methyl)acetamide

C18H17Cl2N3O3 (393.0647)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

Q-100035

19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

C20H15N3O6 (393.0961)


   

6,6-Dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine

4,6-diamino-(1,2-dihydro)-2,2-Dimethyl-1-(2,4,5-trichlorophenoxypropyloxy)-1,3,5-triazine.hcl

C14H18Cl3N5O2 (393.0526)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists

   

Rubitecan

(19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

C20H15N3O6 (393.0961)


Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin. It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and a prodrug. It is a pyranoindolizinoquinoline, a C-nitro compound, a semisynthetic derivative, a tertiary alcohol and a delta-lactone. Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors Rubitecan (RFS 2000), a Camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3].

   
   

1-Thio-beta-D-glucopyranose 1-[3-(methylthio)-N-(sulfooxy)propanimidate]

1-Thio-beta-D-glucopyranose 1-[3-(methylthio)-N-(sulfooxy)propanimidate]

C10H19NO9S3 (393.0222)


   

5-(2-Chloro-6-fluorobenzyl)-6-methyl-2-(prop-2-ynylthio)pyrimidin-4-yl N,N-dimethylcarbamate

5-(2-Chloro-6-fluorobenzyl)-6-methyl-2-(prop-2-ynylthio)pyrimidin-4-yl N,N-dimethylcarbamate

C18H17ClFN3O2S (393.0714)


   
   

3,5-bis(Acetyloxy)-2-(1,3-benzothiazol-2-yl)tetrahydro-2H-pyran-4-yl acetate

3,5-bis(Acetyloxy)-2-(1,3-benzothiazol-2-yl)tetrahydro-2H-pyran-4-yl acetate

C18H19NO7S (393.0882)


   
   

10-nitro camptothecin

10-nitro camptothecin

C20H15N3O6 (393.0961)


   
   
   
   
   
   

CAY10571

4-[5-(4-fluorophenyl)-2-[4-9methylsulfonyl)phenyl]-1H-imidazol-4-yl]-pyridine

C21H16FN3O2S (393.0947)


   

Bendamustine HCL

Bendamustine Hydrochloride

C16H22Cl3N3O2 (393.0778)


   
   

9-nitro-20(S)-camptothecin

9-nitro-20(S)-camptothecin

C20H15N3O6 (393.0961)


Annotation level-1

   

5-Hydroxythiabendazole glucuronide

5-Hydroxythiabendazole glucuronide

C16H15N3O7S (393.0631)


   

Glucoviorylin

{[(E)-[3-(methylsulfanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene]amino]oxy}sulfonic acid

C10H19NO9S3 (393.0222)


   

Sulfaloxic acid

2-[[4-(hydroxymethylcarbamoylsulfamoyl)phenyl]carbamoyl]benzoic acid

C16H15N3O7S (393.0631)


C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

   

N-FMOC-5-AMINO-2-CHLOROBENZOIC ACID

N-FMOC-5-AMINO-2-CHLOROBENZOIC ACID

C22H16ClNO4 (393.0768)


   

4-(4-(4-BROMO-2,6-DIMETHYLPHENYLAMINO)PYRIMIDIN-2-YLAMINO)BENZONITRILE

4-(4-(4-BROMO-2,6-DIMETHYLPHENYLAMINO)PYRIMIDIN-2-YLAMINO)BENZONITRILE

C19H16BrN5 (393.0589)


   

9-nitrocamptothecin

9-nitrocamptothecin

C20H15N3O6 (393.0961)


   

2-amino-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone 4-Methylbenzenesulfonate

2-amino-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone 4-Methylbenzenesulfonate

C16H15F4NO4S (393.0658)


   

N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide

N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide

C16H13Cl2N5OS (393.0218)


   

Ambuside

4-chloro-6-[[(E)-3-oxobut-1-enyl]amino]-1-N-prop-2-enylbenzene-1,3-disulfonamide

C13H16ClN3O5S2 (393.022)


   

platinum acetylacetonate

platinum acetylacetonate

C10H14O4Pt (393.054)


   

6-methoxy-3-methyl-2-[3-methyl-3-(4-nitrophenyl)triazen-1-yl]benzothiazolium chloride

6-methoxy-3-methyl-2-[3-methyl-3-(4-nitrophenyl)triazen-1-yl]benzothiazolium chloride

C16H16ClN5O3S (393.0662)


   

2-[2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazol-4-yl]acetic acid

2-[2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazol-4-yl]acetic acid

C20H15N3O2S2 (393.0606)


   

1H-Isoindol-1-one, 7-bromo-2,3-dihydro-2-[2-[3-(2-pyrimidinyl)phenyl]ethyl]-

1H-Isoindol-1-one, 7-bromo-2,3-dihydro-2-[2-[3-(2-pyrimidinyl)phenyl]ethyl]-

C20H16BrN3O (393.0477)


   

3-(4-Bromophenoxy)-1-(diphenylmethyl)-azetidine

3-(4-Bromophenoxy)-1-(diphenylmethyl)-azetidine

C22H20BrNO (393.0728)


   

3-Butyl-1,1,2-trimethyl-1H-benz[e]indolium iodide

3-Butyl-1,1,2-trimethyl-1H-benz[e]indolium iodide

C19H24IN (393.0953)


   

Bendamustine

Bendamustine Hydrochloride

C16H22Cl3N3O2 (393.0778)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents

   

2-[[4,5-bis(4-chlorophenyl)-1,3-oxazol-2-yl]sulfanyl]propanoic acid

2-[[4,5-bis(4-chlorophenyl)-1,3-oxazol-2-yl]sulfanyl]propanoic acid

C18H13Cl2NO3S (392.9993)


   

Rosiglitazone HCl

Rosiglitazone HCl

C18H20ClN3O3S (393.0914)


Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].

   

2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-CHLOROBENZOIC ACID

2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-CHLOROBENZOIC ACID

C22H16ClNO4 (393.0768)


   

N-FMOC-4-AMINO-2-CHLOROBENZOIC ACID

N-FMOC-4-AMINO-2-CHLOROBENZOIC ACID

C22H16ClNO4 (393.0768)


   
   
   

1,n6-ethenoadenosine 5-monophosphate sodium salt

1,n6-ethenoadenosine 5-monophosphate sodium salt

C12H13N5NaO7P (393.045)


   

3-[4-[4-(Aminosulfonyl)phenyl]-5-methyl-3-isoxazolyl]benzenesulfonamide

3-[4-[4-(Aminosulfonyl)phenyl]-5-methyl-3-isoxazolyl]benzenesulfonamide

C16H15N3O5S2 (393.0453)


   

Be-nzenacetic acid,a-[[(1,1-diMethylethoxy)carbonyl]aMino]-4-hydroxy-3-iodo-

Be-nzenacetic acid,a-[[(1,1-diMethylethoxy)carbonyl]aMino]-4-hydroxy-3-iodo-

C13H16INO5 (393.0073)


   

4-[2-(2-Bromophenyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl]pyridine

4-[2-(2-Bromophenyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl]pyridine

C20H13BrFN3 (393.0277)


   
   

4-bromo-n-[2-(tbdmso)ethyl]benzenesulfonamide

4-bromo-n-[2-(tbdmso)ethyl]benzenesulfonamide

C14H24BrNO3SSi (393.0429)


   

2-Methylthio-AMP TEA salt

2-Methylthio-AMP TEA salt

C11H16N5O7PS (393.0508)


2-Methylthio-AMP (2-MeSAMP) is a selective and direct P2Y12 antagonist. 2-Methylthio-AMP is an inhibitor of ADP-dependent platelet aggregation[1][2][3]. 2-Methylthio-AMP (2-MeSAMP) is a selective and direct P2Y12 antagonist. 2-Methylthio-AMP is an inhibitor of ADP-dependent platelet aggregation[1][2][3].

   

Codeine methylbromide

Codeine methylbromide

C19H24BrNO3 (393.0939)


   

2-Amino-4-(4-bromophenyl)-5-oxo-1,4-dihydro[1]benzopyrano[4,3-b]pyridine-3-carbonitrile

2-Amino-4-(4-bromophenyl)-5-oxo-1,4-dihydro[1]benzopyrano[4,3-b]pyridine-3-carbonitrile

C19H12BrN3O2 (393.0113)


   

4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

C18H20ClN3O3S (393.0914)


   

N-{2-cyano-5-[(cyanomethyl)sulfanyl]-4-phenyl-3-thienyl}-4-fluorobenzenecarboxamide

N-{2-cyano-5-[(cyanomethyl)sulfanyl]-4-phenyl-3-thienyl}-4-fluorobenzenecarboxamide

C20H12FN3OS2 (393.0406)


   

4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide

4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide

C16H15N3O3S3 (393.0276)


   

4-[1-(2,4-Dichlorophenyl)-2-nitroethyl]-5-(2-hydroxyphenyl)-1,2-dihydropyrazol-3-one

4-[1-(2,4-Dichlorophenyl)-2-nitroethyl]-5-(2-hydroxyphenyl)-1,2-dihydropyrazol-3-one

C17H13Cl2N3O4 (393.0283)


   

N,N-dimethylcarbamothioic acid O-[4-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,6-dimethylphenyl] ester

N,N-dimethylcarbamothioic acid O-[4-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,6-dimethylphenyl] ester

C19H20ClNO2S2 (393.0624)


   

1-[[2-(3-Bromo-4-methoxyphenyl)-1-oxoethyl]amino]-3-phenylthiourea

1-[[2-(3-Bromo-4-methoxyphenyl)-1-oxoethyl]amino]-3-phenylthiourea

C16H16BrN3O2S (393.0147)


   

N-[3-chloro-4-[(1S,2R,6S,7R)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]phenyl]pyridine-2-carboxamide

N-[3-chloro-4-[(1S,2R,6S,7R)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]phenyl]pyridine-2-carboxamide

C21H16ClN3O3 (393.088)


   

Aluminum nicotinate

Aluminum nicotinate

C18H12AlN3O6 (393.0541)


C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AD - Nicotinic acid and derivatives

   

3-{[(2,2-Dioxido-1,3-dihydro-2-benzothien-5-YL)amino]methylene}-5-(1,3-oxazol-5-YL)-1,3-dihydro-2H-indol-2-one

3-{[(2,2-Dioxido-1,3-dihydro-2-benzothien-5-YL)amino]methylene}-5-(1,3-oxazol-5-YL)-1,3-dihydro-2H-indol-2-one

C20H15N3O4S (393.0783)


   

{4-[(Carboxymethoxy)carbonyl]-3,3-Dioxido-1-Oxonaphtho[1,2-D]isothiazol-2(1h)-Yl}acetic Acid

{4-[(Carboxymethoxy)carbonyl]-3,3-Dioxido-1-Oxonaphtho[1,2-D]isothiazol-2(1h)-Yl}acetic Acid

C16H11NO9S (393.0155)


   

4-[4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-1H-imidazol-5-yl]pyridine

4-[4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-1H-imidazol-5-yl]pyridine

C21H16FN3O2S (393.0947)


   

3-Carboxy-2,7-dihydroxy-9-methoxy-4-methyl-6,11-dioxotetracen-5-olate

3-Carboxy-2,7-dihydroxy-9-methoxy-4-methyl-6,11-dioxotetracen-5-olate

C21H13O8- (393.061)


   

5-Ethyl-3-imino-6-phenylphenanthridin-8-amine;hydrobromide

5-Ethyl-3-imino-6-phenylphenanthridin-8-amine;hydrobromide

C21H20BrN3 (393.0841)


   

Homidium bromide

Homidium bromide

C21H20BrN3 (393.0841)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors

   

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-4-methoxybenzamide

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-4-methoxybenzamide

C17H13F6NO3 (393.08)


   

1-[7-Acetyl-5-(4-bromo-benzoyl)-1,3,7-triaza-bicyclo[3.3.1]non-3-yl]-ethanone

1-[7-Acetyl-5-(4-bromo-benzoyl)-1,3,7-triaza-bicyclo[3.3.1]non-3-yl]-ethanone

C17H20BrN3O3 (393.0688)


   

2-[[5,6-Bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-1-(4-methoxyphenyl)ethanone

2-[[5,6-Bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-1-(4-methoxyphenyl)ethanone

C20H15N3O4S (393.0783)


   

8-Methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one

8-Methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one

C20H15N3O6 (393.0961)


   

N-[(3-bromo-4-ethoxy-5-methoxyphenyl)methyl]-2,3-dihydro-1,4-benzodioxin-6-amine

N-[(3-bromo-4-ethoxy-5-methoxyphenyl)methyl]-2,3-dihydro-1,4-benzodioxin-6-amine

C18H20BrNO4 (393.0576)


   

5-[1-Benzyl-2-methyl-6-(trifluoromethyl)pyridin-4-ylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione

5-[1-Benzyl-2-methyl-6-(trifluoromethyl)pyridin-4-ylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione

C18H14F3N3O2S (393.0759)


   

3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamide

3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamide

C21H16ClN3O3 (393.088)


   

1-(4-Chlorophenyl)-3-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]thiourea

1-(4-Chlorophenyl)-3-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]thiourea

C21H16ClN3OS (393.0703)


   

N-[(E)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

N-[(E)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C20H15N3O6 (393.0961)


   

(2S)-2-(3-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamide

(2S)-2-(3-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamide

C21H16ClN3O3 (393.088)


   

Platinum diacetylacetonate

Platinum diacetylacetonate

C10H14O4Pt (393.054)


   
   

Dichloroarcyriaflavin A

Dichloroarcyriaflavin A

C20H9Cl2N3O2 (393.0072)


   

6-Methylthioguanosine monophosphate

6-Methylthioguanosine monophosphate

C11H16N5O7PS (393.0508)


   

2-(Methylthio)ethyl glucosinolate

2-(Methylthio)ethyl glucosinolate

C10H19NO9S3 (393.0222)


   

(1r,2r,5s,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

(1r,2r,5s,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

C17H19N3O2S3 (393.0639)


   

11-bromo-4-(methanesulfinylmethyl)-3-methyl-1,3,6-triazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-12-ol

11-bromo-4-(methanesulfinylmethyl)-3-methyl-1,3,6-triazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-12-ol

C16H16BrN3O2S (393.0147)


   

2-{[(6-bromo-1h-indol-3-yl)(hydroxy)methylidene]amino}-3-(2-iminoimidazolidin-4-yl)propanoic acid

2-{[(6-bromo-1h-indol-3-yl)(hydroxy)methylidene]amino}-3-(2-iminoimidazolidin-4-yl)propanoic acid

C15H16BrN5O3 (393.0436)


   

5-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

5-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

C17H19N3O2S3 (393.0639)


   

n-(1,1,15,15-tetrachloropentadeca-1,14-dien-3,12-diyn-8-yl)ethanimidic acid

n-(1,1,15,15-tetrachloropentadeca-1,14-dien-3,12-diyn-8-yl)ethanimidic acid

C17H19Cl4NO (393.0221)


   

(4r)-11-bromo-4-[(r)-methanesulfinylmethyl]-3-methyl-1,3,6-triazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-12-ol

(4r)-11-bromo-4-[(r)-methanesulfinylmethyl]-3-methyl-1,3,6-triazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-12-ol

C16H16BrN3O2S (393.0147)


   

2-hydroxy-6-[4-hydroxy-6-methoxy-2-(methoxycarbonyl)-3-nitrophenoxy]-4-methylbenzoic acid

2-hydroxy-6-[4-hydroxy-6-methoxy-2-(methoxycarbonyl)-3-nitrophenoxy]-4-methylbenzoic acid

C17H15NO10 (393.0696)


   

(1r,2r,5r,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

(1r,2r,5r,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

C17H19N3O2S3 (393.0639)


   

7,19-dichloro-3,10-dimethyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),4,6,8,11,14,17,19,21-nonaene

7,19-dichloro-3,10-dimethyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),4,6,8,11,14,17,19,21-nonaene

C22H17Cl2N3 (393.0799)


   

(2s)-2-{[(6-bromo-1h-indol-3-yl)(hydroxy)methylidene]amino}-3-[(4r)-2-iminoimidazolidin-4-yl]propanoic acid

(2s)-2-{[(6-bromo-1h-indol-3-yl)(hydroxy)methylidene]amino}-3-[(4r)-2-iminoimidazolidin-4-yl]propanoic acid

C15H16BrN5O3 (393.0436)


   

(2r)-3-{[(1-hydroxy-3-methoxy-7-methyl-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(1-hydroxy-3-methoxy-7-methyl-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H19NO7S (393.0882)


   

(2s,10r)-7,19-dichloro-3,10-dimethyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),4,6,8,11,14,17,19,21-nonaene

(2s,10r)-7,19-dichloro-3,10-dimethyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),4,6,8,11,14,17,19,21-nonaene

C22H17Cl2N3 (393.0799)